These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17872870)

  • 1. Taking ACE inhibitors during early pregnancy: is it safe?
    Ray JG; Vermeulen MJ; Koren G
    Can Fam Physician; 2007 Sep; 53(9):1439-40. PubMed ID: 17872870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin converting enzyme inhibitors in pregnancy.
    Mastrobattista JM
    Semin Perinatol; 1997 Apr; 21(2):124-34. PubMed ID: 9201818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taking angiotensin-converting enzyme inhibitors during pregnancy: is it safe?
    Al-Maawali A; Walfisch A; Koren G
    Can Fam Physician; 2012 Jan; 58(1):49-51. PubMed ID: 22267620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposure to angiotensin-converting enzyme inhibitors during first trimester: is it safe to fetus?
    Yip SK; Leung TN; Fung HY
    Acta Obstet Gynecol Scand; 1998 May; 77(5):570-1. PubMed ID: 9654182
    [No Abstract]   [Full Text] [Related]  

  • 5. Are ACE inhibitors safe in pregnancy?
    Lancet; 1989 Aug; 2(8661):482-3. PubMed ID: 2570189
    [No Abstract]   [Full Text] [Related]  

  • 6. Taking ACE inhibitors during pregnancy. Is it safe?
    Ratnapalan S; Koren G
    Can Fam Physician; 2002 Jun; 48():1047-9. PubMed ID: 12113190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From the Centers for Disease Control and Prevention. Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy--United States, Canada, and Israel, 1987-1995.
    JAMA; 1997 Apr; 277(15):1193-4. PubMed ID: 9103332
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical implications of increased congenital malformations after first trimester exposures to angiotensin-converting enzyme inhibitors.
    Cooper WO
    J Cardiovasc Nurs; 2008; 23(1):20-4. PubMed ID: 18158502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy--United States, Canada, and Israel, 1987-1995.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Mar; 46(11):240-2. PubMed ID: 9082178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major congenital malformations after first-trimester exposure to ACE inhibitors.
    Cooper WO; Hernandez-Diaz S; Arbogast PG; Dudley JA; Dyer S; Gideon PS; Hall K; Ray WA
    N Engl J Med; 2006 Jun; 354(23):2443-51. PubMed ID: 16760444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of angiotensin converting enzyme (ACE) inhibitors during pregnancy clearly increases the risk of congenital malformations].
    de Leeuw PW
    Ned Tijdschr Geneeskd; 2006 Jul; 150(29):1605-7. PubMed ID: 16901062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy outcome with ACE-inhibitor use in early pregnancy.
    Steffensen FH; Nielsen GL; Sørensen HT; Olesen C; Olsen J
    Lancet; 1998 Feb; 351(9102):596. PubMed ID: 9492804
    [No Abstract]   [Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in women of childbearing age: risks versus benefits.
    Pucci M; Sarween N; Knox E; Lipkin G; Martin U
    Expert Rev Clin Pharmacol; 2015 Mar; 8(2):221-31. PubMed ID: 25612630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal anuria by ACE inhibitors during pregnancy.
    Lavoratti G; Seracini D; Fiorini P; Cocchi C; Materassi M; Donzelli G; Pela I
    Nephron; 1997; 76(2):235-6. PubMed ID: 9200422
    [No Abstract]   [Full Text] [Related]  

  • 15. Malignant primary hypertension in pregnancy treated with lisinopril.
    Tomlinson AJ; Campbell J; Walker JJ; Morgan C
    Ann Pharmacother; 2000 Feb; 34(2):180-2. PubMed ID: 10676826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitors in pregnancy: a new aspect of indication.
    Rigó J; Adám Z
    Acta Obstet Gynecol Scand; 1999 Feb; 78(2):169. PubMed ID: 10023884
    [No Abstract]   [Full Text] [Related]  

  • 17. ACE inhibitors and birth defects.
    Prescrire Int; 2006 Dec; 15(86):223. PubMed ID: 17167930
    [No Abstract]   [Full Text] [Related]  

  • 18. Is there an embryopathy associated with first-trimester exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists? A critical review of the evidence.
    Polifka JE
    Birth Defects Res A Clin Mol Teratol; 2012 Aug; 94(8):576-98. PubMed ID: 22807387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of antihypertensive drugs on the fetus.
    Rosenthal T; Oparil S
    J Hum Hypertens; 2002 May; 16(5):293-8. PubMed ID: 12082488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists.
    Quan A
    Early Hum Dev; 2006 Jan; 82(1):23-8. PubMed ID: 16427219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.